About Novartis AG

Company Description

Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.

Innovative Medicines
Made up of two business units, Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology & our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.

Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.

Year founded

1859

Served area

Worldwide

Headcount

110,000

Headquarters

Lichtstrasse 35, 4002 Basel – Switzerland

Shareholder information

Shares outstanding

2,204,239,028

IPO

Nov. 18, 1991

Stock exchange(s)

SIX Swiss Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.